Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 12:15 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Physical Disability, Cognitive Impairment, Physical Activity
Interventions: Independent Living Program for Affordable Housing.; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 62 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 13
States / cities: Camden, New Jersey • Cape May, New Jersey • Pennsauken, New Jersey + 1 more

Conditions: Critical Illness, Delirium, Cognitive Impairment, Cognitive Decline, Alzheimer's Disease, Dementia, Circadian Dysrhythmia, Sleep Disturbance
Interventions: SLEEP + COG, COG, SLEEP, AC; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 60 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Parkinson Disease, Cognitive Impairment
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Long COVID, Brain Fog, Cognitive Impairment, Cognitive Dysfunction, Post-Acute COVID-19 Syndrome
Interventions: Processing Speed Training, In-lab Instrumental Activities of Daily Living Training, In-lab Brain Health Training, Transfer Package, Follow Up Phone Calls, Vocational Rehabilitation, Peer Mentoring, Reaction Time Training, Trans-auricular Vagus Nerve Stimulation: High Intensity, Trans-auricular Vagus Nerve Stimulation: Low Intensity; Behavioral · Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Sleep, Alzheimer Disease, Cognitive Impairment, Aging, CBT
Interventions: Sleep intervention, Placebo intervention; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 65 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Fontan Physiology Patients With PB or PLE, Fontan Physiology Patients Without PB or PLE
Interventions: Not listed
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 6 Months and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Cognitive Impairment, Estrogen Deficiency, Menopause, Endothelial Dysfunction, Vascular Stiffness
Interventions: GnRHant + E2, GnRHant + Placebo; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Aurora, Colorado • Boulder, Colorado

Conditions: Cognitive Impairment
Interventions: Aricept; Drug
Lead sponsor: Eisai Limited; Industry
Eligibility: 25 Years to 70 Years
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 2
States / cities: Maywood, Illinois • New York, New York

Conditions: Alzheimer Disease
Interventions: F 18 T807; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Mild Cognitive Impairment
Interventions: Digital Notebook app, Smart Home Prompting; Other
Lead sponsor: Washington State University; Other
Eligibility: 40 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Pullman, Washington

Conditions: Erectile Dysfunction
Interventions: Inflatable Penile Prosthesis; Device
Lead sponsor: Coloplast A/S; Industry
Eligibility: 25 Years to 75 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 3
States / cities: Tampa, Florida • Shreveport, Louisiana • Houston, Texas

Conditions: Brain Injury
Interventions: Goal-oriented attentional self-regulation, Brain Health Education; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Martinez, California

Conditions: Chronic Ischemic Heart Disease, Left Ventricular Dysfunction, Angina, Ischemic Cardiomyopathy
Interventions: Adult stem cells, Placebo; Biological
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 5
States / cities: Gainesville, Florida • Minneapolis, Minnesota • Cleveland, Ohio + 2 more

Conditions: COPD, Pulmonary Hypertension, Exercise, Right Ventricular (RV) Dysfunction, Exercise Training
Interventions: Exercise training; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 40 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Migraine
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Heart Failure With Reduced Ejection Fraction, Endothelial Dysfunction, LVAD
Interventions: Exposure of interest - Use of left ventricular assist device (LVAD); Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Chagas Cardiomyopathy, Cardiac Arrhythmia, Stroke, Left Ventricular Function Systolic Dysfunction, Cardiac Death
Interventions: Not listed
Lead sponsor: Universidade Gama Filho; Other
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Erectile Dysfunction
Interventions: MED3000 (Male), Tadalafil 5mg (Male), MED3000 (Female), Tadalafil 5mg (Female); Device · Drug
Lead sponsor: Futura Medical Developments Ltd.; Industry
Eligibility: 22 Years to 70 Years · Male only
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Parkinson Disease, Cognitive Impairment
Interventions: deep brain stimulation; Device
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Interventions: Finerenone (Kerendia, BAY94-8862); Drug
Lead sponsor: Bayer; Industry
Eligibility: Up to 18 Years
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 22
States / cities: Aurora, Colorado • Wilmington, Delaware • Gainesville, Florida + 18 more

Conditions: Executive Dysfunction, Autism Spectrum Disorder, Adolescent Behavior
Interventions: Unstuck & On Target: High School, Treatment as Usual; Behavioral · Other
Lead sponsor: Children's National Research Institute; Other
Eligibility: 14 Years to 22 Years
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Familial Mediterranean Fever (FMF), Autoinflammation, Periodic Fever, Fever, Genetic Diseases, ROSAH, ALPK1
Interventions: Not listed
Lead sponsor: National Human Genome Research Institute (NHGRI); NIH
Eligibility: 2 Months to 115 Years
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 1994
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Bethesda, Maryland + 1 more

Conditions: Cancer-related Problem/Condition, Cognitive Impairment
Interventions: MAAT-G; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 65 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Mild Cognitive Impairment (MCI), Dementia
Interventions: Insole and ankle device; Device
Lead sponsor: HealthPartners Institute; Other
Eligibility: 55 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Search by objective public record fields.

Improving Aging in Place in Subsidized Housing

A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors

Pacific Northwest Udall Center (PANUC) Clinical Core

Long COVID Brain Fog: Cognitive Rehabilitation Trial

Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease

Plastic Bronchitis and Protein Losing Enteropathy in Children With Single Ventricle Physiology

Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function

The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment

F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)

Evaluating a Digital Memory Notebook App to Improve Functional Independence

Evaluation of the Coloplast Titan® IPP for Maintaining Penile Length While Treating Erectile Dysfunction (ED)

Neural Bases of Cognitive Rehabilitation for Brain Injury

Effectiveness of Stem Cell Treatment for Adults With Ischemic Cardiomyopathy (The FOCUS Study)

Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease

The Identification and Characterization of Autonomic Dysfunction in Migraineurs With and Without Auras

Endothelial Function in Mechanical Circulatory Support

The Signal-averaged ElectrocArdiogram in Long Term Follow-up of Chronic CHagas Disease - RIO de Janeiro Cohort

Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction

Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

A Hybrid Effectiveness-implementation Trial of a High School-based Executive Function Treatment for Autistic Youth

Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics

Memory and Attention Adaptation Training-Geriatrics (MAAT-G)

An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)